TGen Finds Therapeutic Targets for Rare Cancer in Children 06 September 2010 RNAi screening used for the first time to study Ewing’s sarcoma.
Finding Variants in the Human Genome 06 September 2010 HapMap 3 points the way forward for human genetics studies; results reported in Nature.
Sigma® Life Science Enters Genetically Modified Cell Market 06 September 2010 Sigma Life Science launches range of engineered cell lines exploiting CompoZr® zinc finger nuclease technology.
EMBL Scientists Uncover Counterpart of Cerebral Cortex in Marine Worms 03 September 2010 Findings give an idea of what the most ancient higher brain centres looked like, and what our distant ancestors used them for.
Microsoft Excel-based Algorithm Predicts Cancer Prognosis 01 September 2010 The algorithm will enable researchers to quickly generate valuable gene signatures without specialized software or extensive bioinformatics training.
RecipharmCobra Biologics Announces Patent for Novel Antibiotic-Free Plasmid Maintenance System 01 September 2010 oriSELECT plasmid maintenance system wins US and European patents.
Alnylam and Collaborators Publish new Pre-clinical Research on Therapeutic Silencing of Parkinson's Disease Gene 31 August 2010 New Research shows silencing of alpha-synuclein in the Substantia Nigra of non-human primates with an RNAi therapeutic.
First Genetic Link to Common Migraine Exposed 31 August 2010 Genetic variant may increase susceptibility to migraine triggers.
Lonza Acquires Viral Vaccine and Vector Manufacturer Vivante GMP Solutions 31 August 2010 Lonza expands its custom service platform to viral vaccines and gene therapy vectors.
First Picture of Genetic Processes Inside Cell Developed at Penn State 30 August 2010 Penn scientists used X-ray crystallography to built the first-ever image of a protein interacting with the nucleosome.
Gene Scan Finds Link Across Array of Childhood Brain Disorders 27 August 2010 Researchers found gene mutations through whole exome sequencing - a new gene scanning technology that cuts the cost and time of searching for rare mutations.
Sanger Institute and Horizon Collaboration to Advance the Frontiers of Translational Genomics 27 August 2010 The collaboration aims to translate the abundance of new information on human genetic variation into more effective treatments for cancer.
Ambry Genetics Acquires Illumina Hiseq 2000 and First 510(K) Approved Beadxpress® 26 August 2010 The acquisition of Illumina systems allows Ambry to expand its sequencing and genotyping capabilities.
Labcyte Awarded 40th US Patent 25 August 2010 Patent number 7,717,544 describes how in real time acoustic energy is optimized to transfer a droplet of any fluid.
Agilent Updates Human Exon Target Enrichment Tool, Featuring Expressed Genome Content and Optimized Uniformity 25 August 2010 The Latest SureSelect product to emerge from close collaboration with The Broad Institute.
Breakthrough Gene Therapy Prevents Retinal Degeneration 25 August 2010 A new study by Tufts’ researchers demonstrates that non-viral gene therapy can delay the onset of some forms of eye disease and preserve vision.
Castor Bean Genome Published by Research Team Including Scientists from the Venter Institute 25 August 2010 A research team published the sequence and analysis of the castor bean genome in Nature Biotechnology.
Scientists Pinpoint Earliest Steps of Common Form of Muscular Dystrophy 20 August 2010 Findings settle a longstanding question about the roots of facioscapulohumeral muscular dystrophy or FSHD.
Two German-Based Sister Companies Plans to Develop Workflows for Use of 454 Sequencing Systems in Human Genetics 20 August 2010 IMGM Laboratories and the Center for Human Genetics and Laboratory Medicine will use the GS FLX System and GS Junior System for the joint development program.
Discovered Gene Causes Kabuki Syndrome 17 August 2010 NHGRI-supported researchers streamlined DNA sequencing strategies to find rare disease genes quickly.
Diabetes Risk in Children Increases Risk for Weak Bones 17 August 2010 Children at risk for diabetes before they reach puberty also appear to be at risk for weak bones, MCG researchers find.
In NIH-Funded Study, Researchers Uncover Early Step in the Cascade of Brain Events Leading up to Addiction 17 August 2010 Findings represent additional clues to help predict vulnerability to drug abuse.
OriGene Technologies Acquires Blue Heron Biotechnology 17 August 2010 OriGene’s collection of human cDNA clones together with Blue Heron’s gene synthesis capacity provides a whole product solution for the life sciences community.
Chronix Biomedical Adds Mass Sequencing Capabilities to Accelerate Development of its DNA Biomarkers 17 August 2010 Advanced DNA sequencer allows chronix to speed up and expand development of its serum DNA biomarkers for early diagnosis of cancer.
Parent Project Muscular Dystrophy Awards $600K to Nationwide Children's Hospital for Gene Therapy Study 16 August 2010 Dr. Jerry Mendell to lead follistatin gene therapy for Duchenne muscular dystrophy.
K-State Research Team Investigates Mutated Gene's Role in Breast Cancer 16 August 2010 Researcher find that a microscopic gene may play a gigantic role when it comes to cancerous tissue in the human body.
Fluidigm Europe Announces a new Technical Poster Describing its Access Array™ Chip Technology 13 August 2010 New poster describes how Access Array™ chip technology has been used at NCI’s core facility to capture and sequence the entire EBV genome.
Sigma® Life Science and Switchgear Genomics to Co-Develop Simplified MicroRNA Target Validation System 13 August 2010 Combining SwitchGear Genomics’ expertise with Sigma’s lentiviral technology, new target reporter system is expected to simplify miRNA target validation.
Transgenerational Genetic Effects - a Newly Discovered Mode of Inheritance 12 August 2010 A recent article in Augusts issue of Epigenomics has reported that phenotypic variation are in some part attributed to the action of genetic variants in previous generations.
Sigma® Life Science and Switchgear Genomics to Co-Develop Simplified Novel MicroRNA Target Validation System 10 August 2010 SwitchGear Genomics and Sigma’s lentiviral technology combined to simplify miRNA target validation, enabling researchers to investigate gene regulation.